Hui Tang

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study

Keith C. Bible, Vera J. Suman, Julian R. Molina et al. · The Lancet Oncology · 2010 · 414 citations · Full text

Thyroid Cancers, Oncology, Medicine +11

The Endothelin Antagonist Atrasentan Lowers Residual Albuminuria in Patients with Type 2 Diabetic Nephropathy

Dick de Zeeuw, Blai Coll, Dennis L. Andress et al. · Journal of the American Society of Nephrology · 2014 · 290 citations · Full text

Hypertension, Adverse Events, Residual Albuminuria +11

Correlation of IHC and FISH for ALK Gene Rearrangement in Non-small Cell Lung Carcinoma: IHC Score Algorithm for FISH

Eunhee S. Yi, Jennifer M. Boland, Joseph J. Maleszewski et al. · Journal of Thoracic Oncology · 2011 · 261 citations · Full text

Oncology, Oncogenic Agent, Alk Gene Rearrangement +7

Adipose Tissue‐Derived Mesenchymal Stem Cells Improve Revascularization Outcomes to Restore Renal Function in Swine Atherosclerotic Renal Artery Stenosis

Alfonso Eirin, Xiangyang Zhu, James D. Krier et al. · Stem Cells · 2012 · 259 citations · Full text

Engineering, Renal Pathology, Renal Inflammation +26

Temsirolimus and rituximab in patients with relapsed or refractory mantle cell lymphoma: a phase 2 study

Stephen M. Ansell, Hui Tang, Paul J. Kurtin et al. · The Lancet Oncology · 2011 · 154 citations · Full text

Lymphoid Neoplasia, Medicine, Immunology +5